Independent Advisor Alliance bought a new position in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 22,993 shares of the company’s stock, valued at approximately $653,000. Independent Advisor Alliance owned approximately 0.93% of Invesco Nasdaq Biotechnology ETF at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in IBBQ. GeoWealth Management LLC bought a new stake in shares of Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at $451,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Invesco Nasdaq Biotechnology ETF by 7.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 215,722 shares of the company’s stock worth $5,245,000 after purchasing an additional 14,717 shares in the last quarter. Beckerman Institutional LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the 3rd quarter worth about $258,000. IHT Wealth Management LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the 2nd quarter worth about $211,000. Finally, Raymond James Financial Inc. purchased a new position in Invesco Nasdaq Biotechnology ETF during the 2nd quarter valued at about $149,000.
Invesco Nasdaq Biotechnology ETF Stock Down 2.5%
Shares of IBBQ opened at $29.00 on Friday. Invesco Nasdaq Biotechnology ETF has a twelve month low of $20.06 and a twelve month high of $30.50. The stock has a market cap of $65.54 million, a PE ratio of 17.03 and a beta of 0.62. The business’s 50-day moving average price is $29.14 and its 200-day moving average price is $28.79.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Recommended Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
